Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr(−/−) mice

por Rajamoorthi, Ananthi, Lee, Richard G., Baldán, Ángel
Publicado 2018

Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate

por Rajamoorthi, Ananthi, Arias, Noemí, Basta, Jeannine, Lee, Richard G., Baldán, Ángel
Publicado 2017

Therapeutic silencing of fat-specific protein 27 improves glycemic control in mouse models of obesity and insulin resistance

por Langhi, Cédric, Arias, Noemí, Rajamoorthi, Ananthi, Basta, Jeannine, Lee, Richard G., Baldán, Ángel
Publicado 2017

miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity

por Allen, Ryan M, Marquart, Tyler J, Albert, Carolyn J, Suchy, Frederick J, Wang, David Q-H, Ananthanarayanan, Meenakshisundaram, Ford, David A, Baldán, Ángel
Publicado 2012

Doubled lifespan and patient‐like pathologies in progeria mice fed high‐fat diet

por Kreienkamp, Ray, Billon, Cyrielle, Bedia‐Diaz, Gonzalo, Albert, Carolyn J., Toth, Zacharie, Butler, Andrew A., McBride‐Gagyi, Sara, Ford, David A., Baldan, Angel, Burris, Thomas P., Gonzalo, Susana
Publicado 2018

Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice

por Goedeke, Leigh, Salerno, Alessandro, Ramírez, Cristina M, Guo, Liang, Allen, Ryan M, Yin, Xiaoke, Langley, Sarah R, Esau, Christine, Wanschel, Amarylis, Fisher, Edward A, Suárez, Yajaira, Baldán, Angel, Mayr, Manuel, Fernández-Hernando, Carlos
Publicado 2014

Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance

por Price, Nathan L., Singh, Abhishek K., Rotllan, Noemi, Goedeke, Leigh, Wing, Allison, Canfrán-Duque, Alberto, Diaz-Ruiz, Alberto, Araldi, Elisa, Baldán, Ángel, Camporez, Joao-Paulo, Suárez, Yajaira, Rodeheffer, Matthew S., Shulman, Gerald I., de Cabo, Rafael, Fernández-Hernando, Carlos
Publicado 2018